Literature DB >> 31106345

Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis.

Jose R Yuste1,2, María Serrano-Alonso3, Francisco Carmona-Torre1,2, Jose L Del Pozo1,4, Jose I Herrero5.   

Abstract

Entities:  

Year:  2019        PMID： 31106345     DOI： 10.1093/jac/dkz216

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.

Authors:  Sarah Soueges; Claire Triffault-Fillit; Sandrine Roux; Hélène Labussière-Wallet; David Lebeaux; Oana Dumitrescu; Isabelle Morelec; Elisabeth Hodille; Florence Ader
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-10       Impact factor: 3.267

Review 2.  MDR Tuberculosis Treatment.

Authors:  Juan Espinosa-Pereiro; Adrian Sánchez-Montalvá; Maria Luisa Aznar; Maria Espiau
Journal:  Medicina (Kaunas)       Date:  2022-01-26       Impact factor: 2.430

Review 3.  Pharmacokinetics and Pharmacodynamics of Tedizolid.

Authors:  Khalid Iqbal; Aliki Milioudi; Sebastian Georg Wicha
Journal:  Clin Pharmacokinet       Date:  2022-02-07       Impact factor: 6.447

4.  Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.

Authors:  Timothy David Shaw; Mark Smyth; Graham Turner; Michael Hunter
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.